(18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study

PURPOSE: To determine whether interim 3′-deoxy-3′-[(18)F]fluorothymidine (iFLT) PET/CT is a superior predictor of progression-free survival (PFS) compared with interim (18)F-fluorodeoxyglucose (iFDG) PET/CT in patients with diffuse large B cell lymphoma (DLBCL) treated with rituximab, cyclophosphami...

Descripción completa

Detalles Bibliográficos
Autores principales: Minamimoto, Ryogo, Fayad, Luis, Vose, Julie, Meza, Jane, Advani, Ranjana, Hankins, Jordan, Mottaghy, Felix, Macapinlac, Homer, Heinzel, Alexander, Juweid, Malik E., Quon, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263539/
https://www.ncbi.nlm.nih.gov/pubmed/33909086
http://dx.doi.org/10.1007/s00259-021-05353-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263539/
https://www.ncbi.nlm.nih.gov/pubmed/33909086
http://dx.doi.org/10.1007/s00259-021-05353-9

Ejemplares similares